Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in GMAB — Genmab A/S

CIK 1446194 BALA CYNWYD, PA
Back to GMAB Full portfolio

Position in GMAB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$592,390
+$592,390 QoQ
Shares Held
21,565
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GMAB Over Time

Shares Held

Position Value (USD)

Derivatives in GMAB

reported options exposure · as of Jun 30, 2026
CallValue
$6,081,858
CallShares
221,400
PutValue
$1,249,885
PutShares
45,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. GMAB ranks #154 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in GMAB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,081,858 221,400
2026-06-30 $592,390 21,565
2026-06-30 $1,249,885 45,500
2026-03-31 $2,865,444 106,800
2025-12-31 $474,320 15,400
2025-12-31 $18,859,548 612,323
2025-12-31 $705,320 22,900
2025-09-30 $550,587 17,952
2025-09-30 $377,241 12,300
2025-06-30 $627,940 30,394
2025-06-30 $293,372 14,200
2025-06-30 $349,154 16,900
2025-03-31 $248,666 12,700
2025-03-31 $749,914 38,300
2024-12-31 $359,882 17,244
2024-12-31 $315,137 15,100
2024-12-31 $525,924 25,200
2024-09-30 $421,774 17,300
2024-09-30 $701,778 28,785
2024-06-30 $366,898 14,600
2024-06-30 $1,225,012 48,747
2024-03-31 $744,759 24,900
2024-03-31 $864,040 28,888
2024-03-31 $272,181 9,100
2023-12-31 $283,376 8,900
2023-12-31 $516,062 16,208
2023-09-30 $634,860 18,000
2023-09-30 $920,547 26,100
2023-06-30 $494,130 13,000
2023-06-30 $372,498 9,800
2023-06-30 $233,647 6,147
2023-03-31 $972,735 25,761
2023-03-31 $4,391,488 116,300
2023-03-31 $3,813,760 101,000
2022-12-31 $1,267,882 29,917
2022-12-31 $1,123,070 26,500
2022-12-31 $962,026 22,700
2022-09-30 $992,817 30,900
2022-06-30 $291,370 8,968
2022-06-30 $1,757,709 54,100
2022-03-31 $684,525 18,920
2021-12-31 $1,243,647 31,437
2021-12-31 $265,052 6,700
2021-09-30 $2,654,600 60,746
2021-09-30 $388,930 8,900
2021-09-30 $581,210 13,300
2021-06-30 $2,670,282 65,400
2021-06-30 $388,946 9,526
2021-06-30 $841,098 20,600
2021-03-31 $2,137,955 65,122